Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 182

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Prognostic Significance of Expression of a Single MicroRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Open access
Schwind, Sebastian, Maharry, Kati, Radmacher, Michael D., Mrózek, Krzysztof, Holland, Kelsi B., Margeson, Dean, Whitman, Susan P., Hickey, Christopher, Becker, Heiko, Metzeler, Klaus H., Paschka, Peter, Baldus, Claudia D., Liu, Shujun, Garzon, Ramiro, Powell, Bayard L., Kolitz, Jonathan E., Carroll, Andrew J., Caligiuri, Michael A., Larson, Richard A., Marcucci, Guido, Bloomfield, Clara D. · 2010 · Journal of Clinical Oncology

Abstract

Purpose: To evaluate the prognostic significance of expression levels of a single microRNA, miR-181a, in the context of established molecular markers in cytogenetically normal acute myeloid leukemia (CN-AML), and to gain insight into the leukemogenic role of miR-181a. Patients and Methods: miR-181a expression was measured in pretreatment marrow using Ohio State University Comprehensive Cancer Center version 3.0 arrays in 187 younger (< 60 years) adults with CN-AML. Presence of other molecular prognosticators was assessed centrally. A gene-expression profile associated with miR-181a expression was derived using microarrays and evaluated by Gene-Ontology analysis. Results: Higher miR-181a expression associated with a higher complete remission (CR) rate (P = .04), longer overall survival (OS; P = .01) and a trend for longer disease-free survival (DFS; P = .09). The impact of miR-181a was most striking in poor molecular risk patients with FLT3-internal tandem duplication (FLT3-ITD) and/or NPM1 wild-type, where higher miR-181a expression associated with a higher CR rate (P = .009), and longer DFS (P < .001) and OS (P < .001). In multivariable analyses, higher miR-181a expression was significantly associated with better outcome, both in the whole patient cohort and in patients with FLT3-ITD and/or NPM1 wild-type. These results were also validated in an independent set of older (≥ 60 years) patients with CN-AML. A miR-181a-associated gene-expression profile was characterized by enrichment of genes usually involved in innate immunity. Conclusion: To our knowledge, we provide the first evidence that the expression of a single microRNA, miR-181a, is associated with clinical outcome of patients with CN-AML and may refine their molecular risk classification. Targeted treatments that increase endogenous levels of miR-181a might represent novel therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2010.29.2953

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • MicroRNAs Modulate Hematopoietic Lineage Differentiation

    Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257 · cited 1×

    “development and influenced T-cell sensitivity to antigens by modulating T-cell receptor signaling strength.(42,43) Furthermore, miR-181a may also play a regulatory role in earlier steps of hematopoiesis.”
    Background
  • Hox genes in hematopoiesis and leukemogenesis

    Argiropoulos, B., & Humphries, R. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210760 · Cited by 492 · cited 1×

    “These genes are important for developmental processes and have also been linked to leukemogenesis and the selfrenewal of leukemic stem cells.(31,32) We also observed a negative correlation of miR-181a expression with the expression of the A”
    Background

Show all 2 references

Cited by

See all 182

Metadata

Authors
Schwind, S., Maharry, K., Radmacher, M. D., Mrózek, K., Holland, K. B., Margeson, D., Whitman, S. P., Hickey, C., Becker, H., Metzeler, K. H., Paschka, P., Baldus, C. D., Liu, S., Garzon, R., Powell, B. L., Kolitz, J. E., Carroll, A. J., Caligiuri, M. A., Larson, R. A., Marcucci, G., & Bloomfield, C. D.
Venue
Journal of Clinical Oncology
Published
2010-12-20
Volume
28
Issue
36
Pages
5257-5264
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2163337149
Cited by
182
References
2
FWCI
10.95
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic Significance of Expression of a Single MicroRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study. https://app.cochat.ai/papers/10.1200/jco.2010.29.2953
The paper
Schwind, S., Maharry, K., Radmacher, M. D., Mrózek, K., Holland, K. B., Margeson, D., Whitman, S. P., Hickey, C., Becker, H., Metzeler, K. H., Paschka, P., Baldus, C. D., Liu, S., Garzon, R., Powell, B. L., Kolitz, J. E., Carroll, A. J., Caligiuri, M. A., Larson, R. A., . . . Bloomfield, C. D. (2010). Prognostic Significance of Expression of a Single MicroRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2010.29.2953

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.